top of page

Spravato Treatment

Photo By: Carter Petty

Referring patients to the Spravato Program:

For Providers:​​

  • If you are a provider referring a patient for our services, please fill out the form below.

For Self Referrals:​

  • If you are a patient seeking treatment, please fill out our self-referral form below.

Spravato
The new treatment for Depression

SPRAVATO® (esketamine) is an FDA-approved nasal spray for adults with treatment-resistant depression (TRD) who have not responded to at least two antidepressants. It is administered under medical supervision in a certified setting, with patients monitored for at least two hours. SRAVATO® works by targeting the NMDA receptor, influencing glutamate levels in the brain, and has shown rapid antidepressant effects in some patients.

Frequently Asked Questions

Sunrise over Mountains

"There is always light. 
If only we're brave enough to see it. 
If only we're brave enough to be it."

Amanda Gorman

bottom of page